Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer
Abstract Background Triple Negative Breast Cancer (TNBC) is an aggressive form of breast cancer, that represents 10–20% of all breast carcinomas and characterized by the lack of a specific cell surface marker compared to other breast cancer subtypes. Due to the absence of molecular markers for TNBC...
Main Authors: | Farah Jouali, Nabila Marchoudi, Salwa Talbi, Basma Bilal, Mohamed El Khasmi, Houria Rhaissi, Jamal Fekkak |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4811-x |
Similar Items
-
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
by: Yan Xing, et al.
Published: (2019-07-01) -
Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor
by: Soo-Hyeon Kim, et al.
Published: (2021-07-01) -
Highly frequent <it>PIK3CA </it>amplification is associated with poor prognosis in gastric cancer
by: Shi Jing, et al.
Published: (2012-02-01) -
Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway
by: Zhihang Chen, et al.
Published: (2020-01-01) -
Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway
by: Wei Yan, et al.
Published: (2021-06-01)